Working… Menu

Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03064867
Recruitment Status : Suspended (Amendment pending to expand to Phase II)
First Posted : February 27, 2017
Last Update Posted : April 25, 2019
Information provided by (Responsible Party):
Paolo Caimi, MD, Case Comprehensive Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Suspended
Actual Primary Completion Date : December 31, 2018
Estimated Study Completion Date : March 15, 2020